Assessment of plasma concentrations of doxycycline in budgerigars fed medicated seed or water.
OBJECTIVE
To determine whether plasma doxycycline concentrations considered effective for treatment of avian chlamydiosis could be safely established and maintained in budgerigars via administration of doxycycline in water or seed.


METHODS
Prospective study.


METHODS
68 healthy mature budgerigars.


METHODS
In 14-day trials, plasma doxycycline concentrations were measured in budgerigars provided with water containing 0, 50, 100, 200, or 400 mg of doxycycline hyclate/L or a hulled seed diet containing 0, 100, 200, or 400 mg of doxycycline hyclate/kg. On the basis of these results, birds were fed seed containing 300 mg of doxycycline/kg for 42 days, and a control group received unmedicated seed. Blood samples for plasma doxycycline analysis were collected either in the morning on treatment days 4, 7 14, 21, 28, 35, and 42 or in the afternoon on days 12, 26, and 40. Birds were observed daily. On days 14, 28, and 42, physical and plasma biochemical variables, PCV, and total solids concentration were measured; cloacal specimens were obtained for bacteriologic and fungal culture.


RESULTS
During a 14-day period, treatment with water containing < or = 400 mg of doxycycline/L did not maintain plasma doxycycline concentrations of > or = 1 microg/mL, but seed containing 300 mg of doxycycline hyclate/kg maintained mean plasma doxycycline concentrations > 0.98 microg/mL for 42 days without notable adverse effects.


CONCLUSIONS
Results suggest that hulled seed containing 300 mg of doxycycline hyclate/kg can safely establish and maintain plasma doxycycline concentrations that are considered adequate for treatment of chlamydiosis in adult nonbreeding budgerigars.
Flammer
Keven
K
Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27606, USA.
Trogdon
Maureen M
MM
Papich
Mark
M
D000821:Animal Feed; D000818:Animals; D000900:Anti-Bacterial Agents / Q000097:blood* / Q000493:pharmacokinetics / Q000627:therapeutic use; D001715:Bird Diseases / Q000188:drug therapy; D023521:Chlamydophila Infections / Q000188:drug therapy / Q000662:veterinary; D004305:Dose-Response Relationship, Drug; D004318:Doxycycline / Q000097:blood* / Q000493:pharmacokinetics / Q000627:therapeutic use; D005260:Female; D008297:Male; D010311:Parrots / Q000097:blood*; D011446:Prospective Studies
D000900:Anti-Bacterial Agents; D004318:Doxycycline